A randomized, double-blind, placebo-controlled trial of aripiprazole in the treatment of adolescents with schizophrenia: A report on tolerability

被引:0
|
作者
Carson, William H. [1 ]
Robb, Adelaide S. [2 ]
Van-Beek, Alet [1 ]
Johnson, Brian
Mallikaarjun, Suresh
Ivanova, Svetlana [1 ]
Forbes, Robert A. [1 ]
Marcus, Ronald N. [3 ]
Nyilas, Margaretta [1 ]
机构
[1] Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
[2] Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:880 / 881
页数:2
相关论文
共 50 条
  • [41] Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: A double-blind, randomized, and placebo-controlled trial
    Mohammadi, A.
    Ghafari, E.
    Kheramine, S.
    Shirazi, H. Ghaffarian
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 229 - 229
  • [42] The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
    Abbasi, Seyed-Hesameddin
    Behpournia, Haleh
    Ghoreshi, Aboulfazl
    Salehi, Bahman
    Raznahan, Maedeh
    Rezazadeh, Shams-Ali
    Rezaei, Farzin
    Akhondzadeh, Shahin
    SCHIZOPHRENIA RESEARCH, 2010, 116 (2-3) : 101 - 106
  • [43] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [44] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [45] Extract of Ginkgo biloba Treatment for Tardive Dyskinesia in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Zhang, Wu-Fang
    Tan, Yun-Long
    Zhang, Xiang-Yang
    Chan, Raymond C. K.
    Wu, Hao-Ran
    Zhou, Dong-Feng
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (05) : 615 - 621
  • [46] Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study
    Ichikawa, Hironobu
    Mikami, Katsunaka
    Okada, Takashi
    Yamashita, Yushiro
    Ishizaki, Yuko
    Tomoda, Akemi
    Ono, Hiroaki
    Usuki, Chiharu
    Tadori, Yoshihiro
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2017, 48 (05) : 796 - 806
  • [47] Effect of ritanserin on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Malek-Hosseini, Mojgan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 304
  • [48] Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study
    Hironobu Ichikawa
    Katsunaka Mikami
    Takashi Okada
    Yushiro Yamashita
    Yuko Ishizaki
    Akemi Tomoda
    Hiroaki Ono
    Chiharu Usuki
    Yoshihiro Tadori
    Child Psychiatry & Human Development, 2017, 48 : 796 - 806
  • [49] Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH
    Denis, L
    Pagano, F
    Nonis, A
    Robertson, C
    Romano, P
    Boyle, P
    PROSTATE, 1998, 37 (04): : 246 - 252
  • [50] A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia A Preliminary Study
    Niitsu, Tomihisa
    Fujisaki, Mihisa
    Shiina, Akihiro
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Kanahara, Nobuhisa
    Hashimoto, Tasuku
    Shiraishi, Tetsuya
    Fukami, Goro
    Nakazato, Michiko
    Shirayama, Yukihiko
    Hashimoto, Kenji
    Iyo, Masaomi
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 593 - 601